PRR Share Price

Open 0.03 Change Price %
High 0.03 1 Day 0.00 0.00
Low 0.03 1 Week 0.00 0.00
Close 0.03 1 Month 0.00 0.00
Volume 235125 1 Year -0.01 -25.00
52 Week High 0.05
52 Week Low 0.03
PRR Important Levels
Resistance 2 0.03
Resistance 1 0.03
Pivot 0.03
Support 1 0.03
Support 2 0.03
ASX Australia Most Active Stocks
AGO 0.02 0.00%
AGO 0.02 0.00%
AGO 0.02 0.00%
LYC 0.10 11.11%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
TLS 4.24 0.71%
TLS 4.24 0.71%
TLS 4.24 0.71%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
AAU 0.02 100.00%
AAU 0.02 100.00%
AAU 0.02 100.00%
AAU 0.02 100.00%
AAU 0.02 100.00%
BNV 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
More..
ASX Australia Top Losers Stocks
KEY 0.00 -100.00%
KEY 0.00 -100.00%
KEY 0.00 -100.00%
KEY 0.00 -100.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
GDY 0.01 -50.00%
More..

Prima Biomed Ltd (ASX: PRR)

PRR Technical Analysis 5
As on 26th Apr 2017 PRR Share Price closed @ 0.03 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.04 & Strong Sell for SHORT-TERM with Stoploss of 0.03 we also expect STOCK to react on Following IMPORTANT LEVELS.
PRR Target for April
1st Target up-side 0.04
2nd Target up-side 0.04
3rd Target up-side 0.04
1st Target down-side 0.02
2nd Target down-side 0.02
3rd Target down-side 0.02
PRR Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.primabiomed.com.au
PRR Address
PRR
151 Macquarie Street
Level 7
Sydney, NSW 2000
Australia
Phone: 61 2 9276 1224
Fax: 61 2 9276 1284
PRR Latest News
FBR & Co Reiterates "$6.00" Price Target for Prima BioMed Ltd (PBMD)   BBNS   - 26th Apr 17
Analyst Target Price Look at Unisys Corporation (NYSE:UIS) Prima Biomed Ltd ...   Midway Monitor   - 26th Apr 17
Prima BioMed Receives Approval for Third Cohort of Phase I Melanoma Trial   Yahoo Finance   - 19th Apr 17
Prima BioMed Receives A$492144 Tax Refund From Australian Government   Yahoo Finance   - 12th Apr 17
Prima BioMed Ltd: Operational Update   Marketwired (press release)   - 18th Aug 16
Prima BioMed Ltd (PBMD) Gains as Analyst Sees Over 400% Upside   StreetInsider.com   - 31st Dec 15
Why Prima BioMed Limited skyrocketed 43% today   Motley Fool Australia   - 25th May 15
7 reasons Prima BioMed Limited is too risky   Motley Fool Australia   - 22nd May 15
Prima BioMed Announces Strategic Acquisition of Immutep SA   Marketwired (press release)   - 02nd Oct 14
Prima Biomed Ltd. ADR PBMD (US: Nasdaq)   Wall Street Journal   - 18th Apr 12
Interactive Technical Analysis Chart Prima Biomed Ltd ( PRR ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Prima Biomed Ltd
PRR Business Profile
Prima BioMed Ltd., a biotechnology company, researches, develops, and commercializes licensed medical biotechnology products in Australia. Its lead product includes CVac, a cancer vaccine for patients in remission, which has completed two human clinical trials. The company is also developing oral vaccine against human papilloma virus, a virus associated with development of cervical cancer. Prima BioMed Ltd. is based in Sydney, Australia.